China hands 3-1/2-year prison sentence to Astellas' Japanese employee, Nikkei says
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 16 2025
0mins
Should l Buy ?
Source: Reuters
Japanese Employee Sentenced: A Beijing court sentenced a Japanese employee of Astellas Pharma to 3.5 years in prison for espionage, following his detention since March 2023 and indictment a year prior.
China's Stance on Judicial Process: The Chinese foreign ministry stated that judicial authorities handle cases according to the law, emphasizing support for economic cooperation with Japan and a conducive environment for lawful operations of Japanese businesses in China.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
